Further CCK8 experiments identified that the anti-cancer drug efficacy of PEITC in CRC cells was significantly improved after SF3A3 overexpression (P < 0.05, Supplementary Fig. 4D, 4E). This evidence concerns the gene SF3A3 and cancer.